Literature DB >> 7804899

Surgical treatment of colorectal metastases to the liver.

Y Fong1, L H Blumgart, A M Cohen.   

Abstract

Up to one fourth of patients diagnosed with colorectal cancer present with liver metastases, and by the time of death, up to 70 percent of patients with colorectal cancer have metastatic disease to the liver. At present, surgical excision is the standard therapy for resectable liver metastases from colorectal primaries. This article reviews the natural history of colorectal metastases to the liver and results of studies of systemic chemotherapy, surgical resection, and alternative surgical approaches.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7804899     DOI: 10.3322/canjclin.45.1.50

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  21 in total

Review 1.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention.

Authors:  A A J M Van Tilborg; M R Meijerink; C Sietses; J H T M Van Waesberghe; M O Mackintosh; S Meijer; C Van Kuijk; P Van Den Tol
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

Review 3.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

4.  Should hepatic resections be performed at high-volume referral centers?

Authors:  M A Choti; H M Bowman; H A Pitt; J A Sosa; J V Sitzmann; J L Cameron; T A Gordon
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

5.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

6.  Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy.

Authors:  Marco Tampellini; Dario Gned; Chiara Baratelli; Maria Pia Brizzi; Azzurra Ottone; Irene Alabiso; Chiara Bertaggia; Massimo Di Maio; Giorgio Vittorio Scagliotti; Andrea Veltri
Journal:  Radiol Med       Date:  2016-09-06       Impact factor: 3.469

7.  Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.

Authors:  R S Stubbs; R J Cannan; A W Mitchell
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

8.  Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.

Authors:  K Hughes; C M Pinsky; N J Petrelli; F L Moffat; Y Z Patt; L Hammershaimb; D M Goldenberg
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

9.  TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span.

Authors:  K Murakami; K Wierzba; M Sano; J Shibata; K Yonekura; A Hashimoto; K Sato; Y Yamada
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

10.  Pancreatic or liver resection for malignancy is safe and effective for the elderly.

Authors:  Y Fong; L H Blumgart; J G Fortner; M F Brennan
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.